NCT02235155View on ClinicalTrials.gov

Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan

CompletedOBSERVATIONAL
Enrollment

135

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Abortion in Second Trimester
Trial Locations (3)

Unknown

Bukhara Maternity House No. 1, Bukhara

Samarkand Perinatal Center, Samarkand

Clinic No. 2, Tashkent Medical Academy, Tashkent

All Listed Sponsors
lead

Gynuity Health Projects

OTHER

NCT02235155 - Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan | Biotech Hunter | Biotech Hunter